Importantly, high CPT1C-expression levels are associated with poor survival in patients with ESCC, indicating that CPT1C-dependent metabolic alterations promote ESCC progression and that CPT1C is a promising prognostic indicator. This evidence concerns the gene CPT1C and esophageal squamous cell carcinoma.